UNRAVELING THE MECHANISM OF VX-770 ON WTAND G551D-CFTR

被引：0
|
作者：
Lin, W. [1 ]
Jih, K. [1 ]
Hwang, T. [1 ]
机构：
[1] Univ Missouri, Columbia, MO USA
来源：
PEDIATRIC PULMONOLOGY | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：210 / 210
页数：1
相关论文
共 50 条
  • [1] Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation
    Accurso, Frank J.
    Rowe, Steven M.
    Clancy, J. P.
    Boyle, Michael P.
    Dunitz, Jordan M.
    Durie, Peter R.
    Sagel, Scott D.
    Hornick, Douglas B.
    Konstan, Michael W.
    Donaldson, Scott H.
    Moss, Richard B.
    Pilewski, Joseph M.
    Rubenstein, Ronald C.
    Uluer, Ahmet Z.
    Aitken, Moira L.
    Freedman, Steven D.
    Rose, Lynn M.
    Mayer-Hamblett, Nicole
    Dong, Qunming
    Zha, Jiuhong
    Stone, Anne J.
    Olson, Eric R.
    Ordonez, Claudia L.
    Campbell, Preston W.
    Ashlock, Melissa A.
    Ramsey, Bonnie W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (21): : 1991 - 2003
  • [2] EFFICACY AND SAFETY OF VX-770 IN SUBJECTS WITH CYSTIC FIBROSIS AND THE G551D-CFTR MUTATION
    Ramsey, B.
    Dong, Q.
    Yen, K.
    Elborn, J.
    PEDIATRIC PULMONOLOGY, 2011, : 286 - 287
  • [3] VX-770 IN SUBJECTS 6 TO 11 YEARS WITH CYSTIC FIBROSIS AND THE G551D-CFTR MUTATION
    Aherns, R.
    Rodriguez, S.
    Yen, K.
    Davies, J. C.
    PEDIATRIC PULMONOLOGY, 2011, : 283 - 283
  • [4] EFFECT OF VX-770, A CFTR POTENTIATOR, ON SPIROMETRY AND QOL ASSESSMENT IN SUBJECTS WITH CF AND THE G551D-CFTR MUTATION
    Boyle, M.
    Clancy, J. P.
    Rowe, S. M.
    Durie, P.
    Dunitz, J.
    Konstan, M. W.
    Hornick, D.
    Sagel, S. D.
    Ramsey, B.
    Dong, Q.
    Ordonez, C.
    Campbell, P.
    Ashlock, M.
    Accurso, F. J.
    PEDIATRIC PULMONOLOGY, 2009, : 287 - 287
  • [5] IMPROVEMENT IN SWEAT CHLORIDE CONCENTRATION BY THE CFTR POTENTIATOR VX-770 IN SUBJECTS WITH CYSTIC FIBROSIS AND THE G551D-CFTR MUTATION
    Accurso, F.
    Rowe, S. M.
    Durie, P. R.
    Konstan, M. W.
    Dunitz, J.
    Hornick, D.
    Sagel, S. D.
    Boyle, M. P.
    Uluer, A. Z.
    Moss, R. B.
    Donaldson, S.
    Pilewski, J.
    Rubenstein, R. C.
    Aitken, M. L.
    Ramsey, B.
    Freedman, S. D.
    Dong, Q.
    Zha, J.
    Stone, A.
    Olson, E. R.
    Ordonez, C.
    Campbell, P.
    Ashlock, M.
    Clancy, J. P.
    PEDIATRIC PULMONOLOGY, 2009, : 296 - 296
  • [6] Case History: Kalydeco® (VX-770, Ivacaftor), a CFTR Potentiator for the Treatment of Patients with Cystic Fibrosis and the G551D-CFTR Mutation
    Hadida, Sabine
    Van Goor, Frederick
    Dinehart, Kirk
    Looker, Adam R.
    Mueller, Peter
    Grootenhuis, Peter D. J.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 49, 2014, 49 : 383 - 398
  • [7] UNRAVELING THE MECHANISM OF VX-770 (KALYDECO)
    Hwang, K.
    Hwang, T.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 294 - 294
  • [8] NOVEL POTENTIATOR CP-628006 AND VX-770 HAVE DIFFERENT AND ADDITIVE MECHANISMS FOR POTENTIATION OF G551D-CFTR CHANNEL ACTIVITY
    Liu, J.
    Cao, L.
    Berg, A.
    Kim, H.
    Stevens, E.
    Pregel, M.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 210 - 211
  • [9] Discovery of VX-770 (Ivacaftor), a CFTR potentiator for the treatment of cystic fibrosis in G551D patients
    Grootenhuis, Peter D. J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [10] Potential mechanism of Vx-770 uncovered
    Attwood, Claire
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (03) : 206 - 206
12345